ImThera Medical Completes Development of Targeted Hypoglossal Neurostimulation Treatment for OSA

SAN DIEGO--(BUSINESS WIRE)--ImThera Medical, Inc. announced today that it has completed development of its Targeted Hypoglossal Neurostimulation (THN) system for Obstructive Sleep Apnea (OSA).
MORE ON THIS TOPIC